Pfizer is penning a cancer discovery pact with Cartography Biosciences that could max out at $865 million biobucks. The Big Pharma is offering the California biotech up to $65 million in upfront, near ...

Robert F. Kennedy’s position on vaccines is profoundly "anti-science" and making progress would require a new health secretary, Pfizer Chief Executive Albert Bourla said Wednesday. “I have very ...

I last covered Pfizer Inc. stock (PFE) on Nov 8, 2025, with an article titled "Healthcare Q3 Dividend Roundup: I Prefer AbbVie Over Pfizer". The article mainly served as a review for the company's FQ3 ...

Boltz Bags $28M Funding and Pfizer Partnership for Biomolecular AI Boost Your email has been sent Pfizer and Boltz have announced a collaboration aimed at expanding the use of advanced biomolecular AI ...

Although it is the leading infectious cause of birth defects, patients and some doctors know little about cytomegalovirus.

Rheumatologists share how they are using AI platforms for clinical documentation, reducing EHR time, streamlining workflows, ...

Pfizer heads into 2026 with a share price still shaped by the boom and bust of COVID products and a shareholder base that increasingly cares more about income than growth. The company's dividend has ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The South San Francisco company ...

CANOPY reports seven strategies for 2026 to combat workplace burnout and improve mental health, emphasizing hybrid models, ...

A Moderna spokesperson said the company is aware of the lawsuit and will defend itself. Spokespeople for Pfizer, BioNTech and Johnson & Johnson did not immediately respond to requests for comment.

Four New York Times reporters pressed Mr. Trump about a range of topics in a nearly two-hour interview. Here is a transcript of their conversation. President Trump spoke to four New York Times ...

Jan 30 (Reuters) - Global drugmakers are ramping up U.S. manufacturing and stockpiling inventory as the Trump administration considers a 100% tariff on imported branded and patented medicines.